GCIA
OSIR

Gabelli & Co Investment Advisers’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-91,411
Closed -$1.74M – 233
2019
Q1 		$1.74M Buy
+91,411
New +$1.48M 0.22% 72

Other funds holding OSIR

FGAM
Financial Gravity Asset Management Lakeway, Texas $562M AUM

Gabelli & Co Investment Advisers's OSIR Position: Q2 2019 in Review

Gabelli & Co Investment Advisers sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 91,411 shares — an estimated $1.74M sold.

Gabelli & Co Investment Advisers first reported a position in OSIR in Q1 2019 and held it in 1 quarter. The position peaked at $1.74M in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • Gabelli & Co Investment Advisers reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 91,411 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $1.74M.
  • Gabelli & Co Investment Advisers first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Osiris Therapeutics, Inc. Common Stock position peaked at $1.74M in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2019, filed 2 Aug 2019.